Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 218923 (Jul 30, 2025)

Issued July 30, 2025

Issued

July 30, 2025

Application

NDA 505b1 • 218923

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due July 30, 2026Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…